Phosphoglycerate kinase (PGK) is a key glycolytic enzyme that catalyzes the reversible phosphotransfer reaction from 1,3-bisphosphoglycerate to MgADP, to form 3-phosphoglycerate and MgATP. Two isozymes encoded by distinct genes are present in humans: PGK-1, located on Xq-13.3, encodes a ubiquitous protein of 417 amino acids, whereas PGK-2 is testis-specific. PGK1 deficiency is characterized by mild to severe hemolytic anemia, neurological dysfunctions and myopathy; patients rarely exhibit all three clinical features. Nearly 40 cases have been reported, 27 of them characterized at DNA or protein level, and 20 different mutations were described. Here we report the first Italian case of PGK deficiency characterized at a molecular and biochemical level. The patient presented during infancy with hemolytic anemia, increased CPK values, and respiratory distress; the study of red blood cell enzymes showed a drastic reduction in PGK activity. In adulthood he displayed mild hemolytic anemia, mental retardation and severe myopathy. PGK-1 gene sequencing revealed the new missense mutation c.1112T>A (p.Ile371Lys). The mutation was not found among 100 normal alleles, and even if located in the third to the last nucleotide of exon 9, it did not alter mRNA splicing. The p.Ile371Lys mutation falls in a conserved region of the enzyme, near the nucleotide binding site. The mutant enzyme shows reduced catalytic rates toward both substrates (apparent kcat values, 12-fold lower than wild-type) and a decreased affinity toward MgATP (apparent Km, 6-fold higher than wildtype). Moreover, it lost half of activity after nearly 9-min incubation at 45 °C, a temperature that did not affect the wild-type enzyme (t1/2>1 h). The possible compensatory expression of PGK2 isoenzyme was investigated in the proband and in the heterozygote healthy sisters, and found to be absent. Therefore, the highly perturbed catalytic properties of the new variant p.Ile371Lys, combined with protein instability, account for the PGK deficiency found in the patient and correlate with the clinical expression of the disease

A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement : molecular and functional characterization / E. Fermo, P. Bianchi, L.R. Chiarelli, M. Maggi, G.M. Mandarà, C. Vercellati, A.P. Marcello, W. Barcellini, A. Cortelezzi, G. Valentini, A. Zanella. - In: MOLECULAR GENETICS AND METABOLISM. - ISSN 1096-7192. - 106:4(2012 Aug), pp. 455-461. [10.1016/j.ymgme.2012.05.015]

A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement : molecular and functional characterization

A. Cortelezzi;
2012

Abstract

Phosphoglycerate kinase (PGK) is a key glycolytic enzyme that catalyzes the reversible phosphotransfer reaction from 1,3-bisphosphoglycerate to MgADP, to form 3-phosphoglycerate and MgATP. Two isozymes encoded by distinct genes are present in humans: PGK-1, located on Xq-13.3, encodes a ubiquitous protein of 417 amino acids, whereas PGK-2 is testis-specific. PGK1 deficiency is characterized by mild to severe hemolytic anemia, neurological dysfunctions and myopathy; patients rarely exhibit all three clinical features. Nearly 40 cases have been reported, 27 of them characterized at DNA or protein level, and 20 different mutations were described. Here we report the first Italian case of PGK deficiency characterized at a molecular and biochemical level. The patient presented during infancy with hemolytic anemia, increased CPK values, and respiratory distress; the study of red blood cell enzymes showed a drastic reduction in PGK activity. In adulthood he displayed mild hemolytic anemia, mental retardation and severe myopathy. PGK-1 gene sequencing revealed the new missense mutation c.1112T>A (p.Ile371Lys). The mutation was not found among 100 normal alleles, and even if located in the third to the last nucleotide of exon 9, it did not alter mRNA splicing. The p.Ile371Lys mutation falls in a conserved region of the enzyme, near the nucleotide binding site. The mutant enzyme shows reduced catalytic rates toward both substrates (apparent kcat values, 12-fold lower than wild-type) and a decreased affinity toward MgATP (apparent Km, 6-fold higher than wildtype). Moreover, it lost half of activity after nearly 9-min incubation at 45 °C, a temperature that did not affect the wild-type enzyme (t1/2>1 h). The possible compensatory expression of PGK2 isoenzyme was investigated in the proband and in the heterozygote healthy sisters, and found to be absent. Therefore, the highly perturbed catalytic properties of the new variant p.Ile371Lys, combined with protein instability, account for the PGK deficiency found in the patient and correlate with the clinical expression of the disease
Neuromuscular dysfunctions; PGK1 gene; Phosphoglycerate kinase deficiency; Protein instability; Recombinant mutant
Settore MED/15 - Malattie del Sangue
ago-2012
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1096719212002041-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 633.32 kB
Formato Adobe PDF
633.32 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/206080
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 25
social impact